InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Nolet Chris. Director active across 3 companies, notably Revance Therapeutics, Inc.. In total, 9 disclosures have been published. Activity tracked since 5 May 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
28,606 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015339:0
15,000 shares0Common StockSEC:0001479290-24-000088:0
3,534 shares0Common StockSEC:0001479290-23-000062:0
36,497 shares0Common StockSEC:0001493152-23-001628:0
32,500 shares0Voting Common StockSEC:0001213900-22-063938:0
50,900 shares0Common StockSEC:0001493152-22-027578:0
6,059 shares0Common StockSEC:0001479290-22-000063:0
4,013 shares0Common StockSEC:0001479290-21-000112:0
4,013 shares0Common StockSEC:0001479290-21-000112
9 of 9 declarations
